MILLIGAN DAVID V 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Sep 19, 2018
Insider Transaction Report
Form 4
MILLIGAN DAVID V
Director
Transactions
- Exercise/Conversion
Common Stock
2018-09-18$9.45/sh+20,000$189,000→ 20,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-09-18−20,000→ 0 totalExercise: $9.45From: 2017-07-22Exp: 2026-07-22→ Common Stock (20,000 underlying)